Zoetis (ZTS)
(Delayed Data from NYSE)
$147.38 USD
+1.59 (1.09%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $147.41 +0.03 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Zoetis Inc. has a PEG ratio of 2.51 compared to the Medical - Drugs industry's PEG ratio of 1.32.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ZTS 147.38 +1.59(1.09%)
Will ZTS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZTS
Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect
Countdown to Zoetis (ZTS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Zoetis (ZTS) Fell More Than Broader Market
Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Other News for ZTS
Top 15 High-Growth Dividend Stocks For August 2025
How Do Investors Really Feel About Zoetis?
Notable Thursday Option Activity: ZTS, WFC, BROS
MOO: A Fertile Investment
Polen Global Growth Portfolio Q2 2025 Commentary